BioLife Solutions Stock Forecast

Stock Price Forecast

According to 9 analysts polled by S&P Global, BioLife Solutions stock has a consensus rating of "Strong Buy" and an average price target of $32.11. The average 1-year stock price forecast is 13.70% higher than the current stock price, while the lowest is $30 (+6.23%) and the highest is $34 (+20.40%).

Price Target: $32.11 (+13.70%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$30	$32.11	$32	$34
Change	+6.23%	+13.70%	+13.31%	+20.40%

* Price targets were last updated on Jun 1, 2026.

Analyst Ratings

The average analyst rating for BioLife Solutions stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	9	9	9	9	9	8
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	10	10	10	10	9

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Matt Hewitt Craig-Hallum	Craig-Hallum	Buy Maintains n/a	Buy	Maintains	n/a	n/a	Jun 25, 2026
Yi Chen H.C. Wainwright	H.C. Wainwright	Buy Reiterates $32	Buy	Reiterates	$32	+13.31%	Jun 1, 2026
Jason McCarthy Maxim Group	Maxim Group	Buy Maintains $34	Buy	Maintains	$34	+20.40%	May 13, 2026
Thomas Flaten Lake Street	Lake Street	Buy Maintains $33	Buy	Maintains	$33	+16.86%	May 8, 2026
Brendan Smith TD Cowen	TD Cowen	Buy Maintains $33	Buy	Maintains	$33	+16.86%	May 8, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

113.87M

from 96.21M

18.35%

from 96.21M

Revenue Next Year

134.59M

from 113.87M

18.19%

from 113.87M

EPS This Year

0.25

from 0.13

91.86%

from 0.13

EPS Next Year

0.33

from 0.25

32.00%

from 0.25

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	119.16M	76.24M	68.02M	74.65M	96.21M	113.87M
Revenue Growth	147.79%	-36.02%	-10.79%	9.75%	28.89%	18.35%
Gross Profit	38.18M	46.91M	41.32M	50.10M	62.12M	74.13M
Gross Margin	32.04%	61.53%	60.75%	67.11%	64.56%	65.10%
Operating Income	-29.52M	-10.68M	-19.40M	-4.48M	-1.08M	3.59M
Net Income	-8.91M	-139.81M	-68.00M	-20.18M	-4.60M	8.36M
EPS	-	-	-	-	0.13	0.25
EPS Growth	-	-	-	-	-	91.86%
Forward PE	-	-	-	-	-	112.96
Free Cash Flow	-13.40M	-6.54M	15.50M	44.83M	12.44M	9.14M
No. Analysts	-	-	-	-	-	9

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	114.4M
Avg	113.9M
Low	113.5M

Revenue Growth

Revenue Growth	2026	2027	2028
High	18.9%
Avg	18.4%
Low	17.9%

EPS Forecast

EPS	2026	2027	2028
High	0.25
Avg	0.25
Low	0.25

EPS Growth

EPS Growth	2026	2027	2028
High	91.9%
Avg	91.9%
Low	91.9%